The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the pharmaceutical landscape . Despite its initial success and creation of vast in sales, the intellectual property lapse has opened the way for competing medications, significantly reducing earnings opportunities. This transition ra